Yangzhou Liberty Pharmaceutical Co. Ltd

Yangzhou Liberty Pharmaceutical Co., Ltd. is a prominent manufacturer in the pharmaceutical industry, specialising in the production of Active Pharmaceutical Ingredients (APIs). Established as a joint venture between Jiangsu Lianhuan Pharmaceutical Group and Hong Kong Bohua Group, the company has developed significant expertise in the manufacture of pharmaceutical products, notably Doxycycline Hyclate and Oxytetracycline Hydrochloride. With stringent quality assurance measures in place, Yangzhou Liberty Pharmaceutical has successfully passed US FDA inspections and obtained various certifications, including CEP, EU-GMP, and GMP, alongside Written Confirmation.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Doxycycline Hyclate production
- Oxytetracycline Hydrochloride production
- Quality assurance and compliance certifications

Yangzhou Liberty Pharmaceutical Co., Ltd. continues to be a key player in the pharmaceutical sector, committed to delivering high-quality products to its clients. For more information, please visit libertypharma.cn.